AdRes Health Economics & Outcomes Research

What AdRes Health Economics & Outcomes Research does

AdRes Health Economics & Outcomes Research (legal entity AdRes Srl) is a privately held, Turin-based consulting firm specializing in health economics and outcomes research (HEOR) for the pharmaceutical and healthcare sectors. The firm offers four core consultancy lines — pharmacoeconomic modeling and simulation, market access support (HTA dossiers, pricing/reimbursement submissions), real-world evidence study design and execution, and scientific evidence evaluation (systematic reviews, meta-analyses, network meta-analyses, Bayesian hierarchical modeling) — alongside structured pharmacoeconomics training programs. Its client base is concentrated in pharmaceutical and biotech companies, with secondary segments in HTA agencies/payers and healthcare providers (hospitals and clinical research centers). Geographically, AdRes operates nationally within Italy and internationally, with its registered office at Via Alfieri 17 and main office at Via Cervino 75 in Turin.

Underlying the consultancy work, AdRes has built three proprietary software assets: a QALY Shortfall Calculator providing Italy-specific quality-adjusted life expectancy estimates by age and sex (supporting NICE-style severity-of-disease modifier assessments), the Easier App (a smartphone application for time-and-motion studies with real-time centralized data collection), and custom Electronic Data Collection Systems developed with third-party engineering partners for prospective observational studies. The firm has been actively publishing peer-reviewed research since at least 2002, spanning oncology, respiratory, cardiovascular, diabetes, and nutrition therapeutic areas, with multiple 2024-2025 publications in journals such as ClinicoEconomics and Outcomes Research and Nutrients. Scientific Director Lorenzo Pradelli has additionally authored/co-authored several textbooks, including Pharmacoeconomics: Principles and Practice.

AdRes is revenue-generating exclusively through professional services on a consulting basis (no public pricing disclosed), reaching clients via direct B2B sales, scientific publications, conference participation, and a LinkedIn presence. The firm holds ISO 9001 (quality management) and ISO 27001 (information security) certifications, supporting its eligibility for sensitive pharmaceutical and HTA engagements. The team comprises 9 people led by founders Simone Eandi (MBA) and Lorenzo Pradelli (MD), supplemented by senior researchers with PharmD, PhD, and MSc credentials in modeling, statistics, and clinical research. The firm operates without disclosed external funding, parent company, or acquisition activity.

Name

AdRes Health Economics & Outcomes Research

Legal name

AdRes Srl

Website

https://adreshe.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

AdRes Srl is a privately held, Turin-based health economics and outcomes research consultancy serving pharmaceutical companies, HTA agencies, and healthcare providers with pharmacoeconomic modeling, market access, real-world evidence, and evidence synthesis services, supported by proprietary software tools.

Ownership category

akta.pro rank

Product category

Health Economics & Outcomes Research Consulting

SIC

Services-Prepackaged Software (7372)

akta.pro industry

PRIMARYHLACAOAA

Electronic Data Capture (EDC) Platforms

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

• Health economics consulting
• Pharmacoeconomic modeling
• Real-world evidence
• Market access services
• Outcomes research

Headquarters

HQ city

Turin

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Consultancy Services: AdRes generates revenue through specialized health economics and outcomes research consultancy services including pharmacoeconomic modeling, market access strategy, real-world evidence studies, and scientific evidence evaluation for pharmaceutical and healthcare companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

AdRes is a specialized consulting firm offering health economics and outcomes research (HEOR) services to pharmaceutical companies and healthcare decision-makers. Core deliverables include pharmacoeconomic modeling (Markov, Monte Carlo, DES, DICE models), market access dossiers, real-world evidence studies, and systematic literature reviews. The firm complements these consultancy services with proprietary software tools including the QALY Shortfall Calculator, the Easier App for Time&Motion studies, and custom Electronic Data Collection (EDC) systems.

Product overview

AdRes Health Economics & Outcomes Research operates as a specialized consulting firm offering a portfolio of software tools (QALY Shortfall Calculator, Easier App, Electronic Data Collection Systems) combined with professional consultancy services in pharmacoeconomic modelling, market access, real-world evidence studies, and scientific evidence evaluation. The company also provides structured training programs in pharmacoeconomics and health economics methodologies.

Differentiator

Problem solved

Functional benefit

Brands

• Easier App: Mobile application developed to support and facilitate normal daily activities, optimizing the data collection process for Time&Motion studies
• QALY Shortfall Calculator
• Electronic Data Collection Systems

Products and services

• QALY Shortfall Calculator Online calculator that provides updated quality-adjusted life expectancy (QALE) estimates for the Italian population by age and sex, enabling calculation of absolute and proportional QALY reductions for NICE severity-of-disease modifier assessments. Used by HEOR researchers, HTA agencies, and pharmaceutical companies building cost-effectiveness dossiers.
• Easier App Smartphone-based application for Time&Motion studies enabling healthcare personnel to track normal workflow, collect data, and transmit information to a central database in real time, with remote monitoring and integration of patient/professional questionnaires.
• Electronic Data Collection Systems Custom-developed data collection and decision-support systems for prospective observational studies and the creation of professional research networks, built through partnerships with leading development and communication companies.
• Models and Simulations Services Development and adaptation of pharmacoeconomic models for pharmaceutical and healthcare clients, including decision trees, Markov models, Markov/Monte Carlo models with probabilistic sensitivity analysis, fully probabilistic Bayesian models, DES models, DICE models, dynamic transmission models, and hybrid structures.
• Market Access Services Market access consultancy including dossier preparation for pricing and reimbursement, HTA reports, medical writing, and market opportunity analyses to support product authorization stages for pharmaceutical clients.
• Real World Evidence Services Organization and coordination of retrospective or prospective observational studies with full-service management including study design, statistical analyses, clinical center engagement, and ethics committee coordination to generate real-world evidence for pharmaceutical and healthcare clients.
• Scientific Evidence Evaluation Services Evidence synthesis including focused, critical, and systematic reviews, meta-analyses, network meta-analyses, trial sequential analysis, Bayesian hierarchical modelling, and GRADE quality assessments for pharmaceutical and HTA clients.
• Pharmacoeconomics Training Training programs covering pharmacoeconomics principles, methodologies including cost-minimization, cost-effectiveness, cost-utility, cost-benefit analyses, and patient-reported outcomes (PRO) instruments, targeted at healthcare and pharmaceutical professionals.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Evidera (PPD / Thermo Fisher): Evidera is a large HEOR and RWE consultancy now operating within Thermo Fisher's PPD clinical research organisation. Provides the same pharmacoeconomic modelling and market access services as AdRes at much greater scale and global reach.
• ICON plc: ICON plc acquired PRA Health and Symphony Health to build one of the largest HEOR and real-world evidence practices. Comparable to AdRes in offering pharmacoeconomic modelling, market access, and RWE, but with global delivery capacity.
• Parexel International: Parexel runs a dedicated HEOR and market access consulting practice serving pharma sponsors. Direct overlap with AdRes on cost-effectiveness modelling, HTA submissions, and payer engagement across multiple geographies.
• IQVIA: IQVIA is the largest global HEOR, RWE, and market access consultancy with thousands of health economics specialists. It competes with AdRes on pharma pharmacoeconomic modelling and HTA dossier work but at vastly greater scale and geographic reach.

Direct peers

• Open Health: Open Health is a UK-headquartered HEOR and market access consultancy offering economic modelling, HTA submissions, and real-world evidence services to pharma. Closely comparable to AdRes in specialisation and project-level delivery.
• Putnam Associates: Putnam is a US-focused life sciences strategy and HEOR consulting firm delivering pharmacoeconomic models, pricing, and market access work for pharma. Comparable in specialisation though typically larger and US-centric.
• THEMA Consulting Group: THEMA is an Italy-based HEOR and pharmacoeconomic consultancy offering nearly identical services to AdRes — modelling, RWE, market access, and HTA dossiers for pharma clients in Italy and Europe. The closest like-for-like competitor.
• BresMed Health Solutions: BresMed is a UK-based specialist HEOR consultancy offering economic modelling, evidence synthesis, and market access services. Highly comparable in size and specialisation, though UK-centric in geographic focus.
• RTI Health Solutions: RTI Health Solutions is a not-for-profit-affiliated HEOR consultancy providing economic modelling, patient-reported outcomes, and RWE research. Direct overlap with AdRes on methodology and pharma client base.

Emerging players

• Cytel: Cytel is a biostatistics and HEOR-focused firm providing Bayesian modelling, health economics, and RWE services. Overlaps with AdRes on Bayesian / Markov modelling methodology but is broader across clinical statistics.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/adres-heor

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AdRes Health Economics & Outcomes Research